The VTH conducts investigative clinical trials to determine the safety or effectiveness of a new method of diagnosis or modality of treatment for animal diseases. Some diseases occuring in companion animals model diseases in humans. The results of our clinical trials may provide the new knowledge needed to advance both animal and human health.
All clinical trials are reviewed and approved by the Veterinary Teaching Hospital Board of the Virginia-Maryland Regional College of Veterinary Medicine.
At any given time, there are numerous clinical trials beginning and ending throughout the Teaching Hospital. While it would be impractical to list all of them, you can learn about some of our featured trials below:
Principal Investigator: Dr. John Rossmeisl, Associate Professor, Neurology/Neurosurgery
This clinical trial is a collaboration between investigators at the Virginia-Maryland Regional College of Veterinary Medicine (VA-MD Vet Med) and the Thomas K. Hearn Brain Tumor Research Center at the Wake Forest School of Medicine. The treatment administered in the trial involves a procedure termed Convection Enhanced Delivery (CED) of molecularly targeted cytotoxins, which are types of chemotherapeutic drugs, to the patient’s brain tumor. The chemotherapeutic drugs used in this trial are unique in that they are designed to affect only cancerous cells, and not normal brain tissue.
Learn more about this research on the Brain Tumor Clinical Trials for Dogs website.